Immunic IMUX
NASDAQ IMUX
$8.12 +0.08 (+1.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Immunic (IMUX) Minority Interest (2013 - 2014)

Updated

Immunic (IMUX) recorded Minority Interest of $104.71 million in Q1 2014, up 25.4% from the prior quarter.

Analysis

Immunic (IMUX) Minority Interest (2013 - 2014) Analysis & Trends

At the end of FY2013, Immunic reported Minority Interest of $83.48 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Immunic 341.81 Mn -50.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 104.71 Mn
Dec 31, 2013 83.48 Mn
API Access

Immunic Minority Interest API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=minority-interest&ticker=IMUX&period=max&api_key=YOUR_API_KEY